⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Polypharmacy and Potentially Inappropriate Prescribing in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-20 — Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer’s Disease: cross-connection with anticholinergic-exposure: Brain Safe app operationalizes deprescribing of a specific high-risk drug class within the broader polypharmacy/PIM framework, linking anticholinergic burden reduction to the general problem of inappropriate prescribing in older adults. (novelty: 3)
Open questions
Related
Contributing findings
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
02-sep-2026
novelty 2
per-area 2
introduces